Jari Kellokoski - Concepedia

Author

Jari Kellokoski

Also Known As

J K Kellokoski, J Kellokoski, J. K. Kellokoski, J. Kellokoski, J.K. Kellokoski, Jari K. Kellokoski, Jari Kellokoski, M A Anttila , K I Moisio

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Eastern Finland Kuopio University Hospital Tampere University Hospital University of Turku

About

Jari Kellokoski is an author at University of Eastern Finland specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	983
2	Public Health	3	3	98
3	Health Sciences	2	2	61
4	Education	1	1	25
5	Natural Sciences	1	1	47

Jari Kellokoski

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis Johanna M. Pellikainen, Kirsi Ropponen, Vesa Kataja, Clinical Cancer Research	2004	340
High frequency of <scp>BRAF</scp><scp>V600E</scp> mutations in ameloblastoma Kari J. Kurppa, Javier Catón, Peter R. Morgan, The Journal of Pathology Mutant BrafErbb ReceptorsMedicineGeneticsPathology	2013	296
Surgical-orthodontic treatment and patients’ functional and psychosocial well-being Riitta Pahkala, Jari Kellokoski American Journal of Orthodontics and Dentofacial Orthopedics Quality Of LifePsychiatryPsychologyOrthodontic ResearchMental Health	2007	120
Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections Jari Kellokoski, Stina Syrjänen, Fuju Chang, Journal of Oral Pathology and Medicine	1992	115
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. Jari Karjalainen, Jari Kellokoski, Matti Eskelinen, Journal of Clinical Oncology	1998	108
p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis Kirsi Ropponen, Jari Kellokoski, P. Lipponen, British Journal of Cancer	1999	70
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma Ari Kosunen, Risto Pirinen, Kirsi Ropponen, Oral Oncology OncologyCd44 ExpressionMedicineImmunologyClinicopathological Factors	2006	68
Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma Ari Kosunen, Kirsi Ropponen, Jari Kellokoski, Oral Oncology Poor SurvivalMedicineOral CavityOral BiologyPathology	2003	66
Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections Jari Kellokoski, Stina Syrjänen, Merja Yliskoski, Oral Microbiology and Immunology	1992	62
Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Johanna M. Pellikainen, Vesa Kataja, Kirsi Ropponen, PubMed	2002	61

Page 1